Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.01
Net Income/Share$-0.75
Operating CF/Share$-0.63
Free CF/Share$-0.63
Cash/Share$0.91
Book Value/Share$0.73
Tangible Book/Share$0.73
Equity/Share$0.73
Interest Debt/Share$0.02
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$117.88M
Enterprise Value$108.76M
P/E Ratio-2.32P/S Ratio235.29P/OCF Ratio-2.77
P/FCF Ratio-2.79
P/B Ratio2.40P/TB Ratio2.40
EV/Sales217.08EV/EBITDA-2.09
Graham Valuation
Graham Number--
Graham Net-Net$0.68
Profitability
Earnings Yield-43.08%FCF Yield-35.86%ROE-77.21%ROIC-107.84%Return on Tangible Assets-79.06%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.10%
CapEx/Revenue8.78%
CapEx/Depreciation0.04
SBC/Revenue1124.95%
SG&A/Revenue2180.04%
R&D/Revenue7977.25%
Liquidity & Solvency
Debt/Equity0.02Debt/Assets0.02Debt/Market Cap0.01
Net Debt/EBITDA0.18
Current Ratio4.20Interest Coverage0.00xIncome Quality0.84Efficiency
Days Sales Outstanding185 days
Days Payables Outstanding77 days
Days Inventory0 days
Receivables Turnover1.97x
Payables Turnover4.74x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$48.79M
Working Capital$47.09M
Invested Capital$48.52M
Intangibles/Assets0.00%